Cite
MLA Citation
Denise Yardley et al.. “Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.” Trials, vol. 16, no. 1, 2015, pp. 1–10. http://access.bl.uk/ark:/81055/vdc_100080382653.0x00003c